Researchers are conducting a case-control study to investigate a potential association between the use of a newly approved oral biologic for severe plaque psoriasis and the subsequent development of drug-induced lupus erythematosus (DILE). The investigators identify 150 patients from a national rheumatology database who were recently diagnosed with DILE. They also randomly select 150 healthy volunteers without DILE from a primary care registry, matched for age and sex, to serve as a comparison group. A detailed review of the participants' pharmacological histories reveals that 100 of the patients with DILE had been prescribed the new oral biologic prior to their diagnosis. Among the comparison group, 50 subjects had a history of taking the same medication. Based on the data collected, which of the following is the odds ratio for developing DILE associated with the use of this oral biologic?
- A
- B
- C
- D
- Answer